These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 24958706)

  • 21. Identification of ElpA, a Coxiella burnetii pathotype-specific Dot/Icm type IV secretion system substrate.
    Graham JG; Winchell CG; Sharma UM; Voth DE
    Infect Immun; 2015 Mar; 83(3):1190-8. PubMed ID: 25605765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effector Cig57 Hijacks FCHO-Mediated Vesicular Trafficking to Facilitate Intracellular Replication of Coxiella burnetii.
    Latomanski EA; Newton P; Khoo CA; Newton HJ
    PLoS Pathog; 2016 Dec; 12(12):e1006101. PubMed ID: 28002452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysosomal degradation products induce
    Newton P; Thomas DR; Reed SCO; Lau N; Xu B; Ong SY; Pasricha S; Madhamshettiwar PB; Edgington-Mitchell LE; Simpson KJ; Roy CR; Newton HJ
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6801-6810. PubMed ID: 32152125
    [No Abstract]   [Full Text] [Related]  

  • 24. The Coxiella burnetii cryptic plasmid is enriched in genes encoding type IV secretion system substrates.
    Voth DE; Beare PA; Howe D; Sharma UM; Samoilis G; Cockrell DC; Omsland A; Heinzen RA
    J Bacteriol; 2011 Apr; 193(7):1493-503. PubMed ID: 21216993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary Murine Macrophages as a Tool for Virulence Factor Discovery in Coxiella burnetii.
    Case EDR; Mahapatra S; Hoffpauir CT; Konganti K; Hillhouse AE; Samuel JE; Van Schaik EJ
    Microbiol Spectr; 2022 Aug; 10(4):e0248421. PubMed ID: 35913176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Large-scale identification and translocation of type IV secretion substrates by Coxiella burnetii.
    Chen C; Banga S; Mertens K; Weber MM; Gorbaslieva I; Tan Y; Luo ZQ; Samuel JE
    Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21755-60. PubMed ID: 21098666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Refining the plasmid-encoded type IV secretion system substrate repertoire of Coxiella burnetii.
    Maturana P; Graham JG; Sharma UM; Voth DE
    J Bacteriol; 2013 Jul; 195(14):3269-76. PubMed ID: 23687269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Coxiella burnetii ankyrin repeat domain-containing protein family is heterogeneous, with C-terminal truncations that influence Dot/Icm-mediated secretion.
    Voth DE; Howe D; Beare PA; Vogel JP; Unsworth N; Samuel JE; Heinzen RA
    J Bacteriol; 2009 Jul; 191(13):4232-42. PubMed ID: 19411324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between host cell mitochondria and Coxiella burnetii.
    Yek KQ; Stojanovski D; Newton HJ
    Int Rev Cell Mol Biol; 2023; 377():1-17. PubMed ID: 37268347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expressed in the yeast Saccharomyces cerevisiae, human ERK5 is a client of the Hsp90 chaperone that complements loss of the Slt2p (Mpk1p) cell integrity stress-activated protein kinase.
    Truman AW; Millson SH; Nuttall JM; King V; Mollapour M; Prodromou C; Pearl LH; Piper PW
    Eukaryot Cell; 2006 Nov; 5(11):1914-24. PubMed ID: 16950928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EirA Is a Novel Protein Essential for Intracellular Replication of Coxiella burnetii.
    Kuba M; Neha N; Newton P; Lee YW; Bennett-Wood V; Hachani A; De Souza DP; Nijagal B; Dayalan S; Tull D; McConville MJ; Sansom FM; Newton HJ
    Infect Immun; 2020 May; 88(6):. PubMed ID: 32205404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of the yeast Rlm1 transcription factor by the Mpk1 cell wall integrity MAP kinase.
    Jung US; Sobering AK; Romeo MJ; Levin DE
    Mol Microbiol; 2002 Nov; 46(3):781-9. PubMed ID: 12410835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coxiella burnetii express type IV secretion system proteins that function similarly to components of the Legionella pneumophila Dot/Icm system.
    Zamboni DS; McGrath S; Rabinovitch M; Roy CR
    Mol Microbiol; 2003 Aug; 49(4):965-76. PubMed ID: 12890021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coxiella burnetii Blocks Intracellular Interleukin-17 Signaling in Macrophages.
    Clemente TM; Mulye M; Justis AV; Nallandhighal S; Tran TM; Gilk SD
    Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30061378
    [No Abstract]   [Full Text] [Related]  

  • 35. A protein-protein interaction map reveals that the Coxiella burnetii effector CirB inhibits host proteasome activity.
    Fu M; Liu Y; Wang G; Wang P; Zhang J; Chen C; Zhao M; Zhang S; Jiao J; Ouyang X; Yu Y; Wen B; He C; Wang J; Zhou D; Xiong X
    PLoS Pathog; 2022 Jul; 18(7):e1010660. PubMed ID: 35816513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Type 4B Secretion System Substrates That Are Conserved among Coxiella burnetii Genomes and Promote Intracellular Growth.
    Larson CL; Pullman W; Beare PA; Heinzen RA
    Microbiol Spectr; 2023 Jun; 11(3):e0069623. PubMed ID: 37199620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Farnesylated Coxiella burnetii Effector Forms a Multimeric Complex at the Mitochondrial Outer Membrane during Infection.
    Fielden LF; Moffatt JH; Kang Y; Baker MJ; Khoo CA; Roy CR; Stojanovski D; Newton HJ
    Infect Immun; 2017 May; 85(5):. PubMed ID: 28242621
    [No Abstract]   [Full Text] [Related]  

  • 38. Functional similarities between the icm/dot pathogenesis systems of Coxiella burnetii and Legionella pneumophila.
    Zusman T; Yerushalmi G; Segal G
    Infect Immun; 2003 Jul; 71(7):3714-23. PubMed ID: 12819052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of lipids in Coxiella burnetii infection.
    Gilk SD
    Adv Exp Med Biol; 2012; 984():199-213. PubMed ID: 22711633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Coxiella burnetii T4SS effector protein AnkG hijacks the 7SK small nuclear ribonucleoprotein complex for reprogramming host cell transcription.
    Cordsmeier A; Rinkel S; Jeninga M; Schulze-Luehrmann J; Ölke M; Schmid B; Hasler D; Meister G; Häcker G; Petter M; Beare PA; Lührmann A
    PLoS Pathog; 2022 Feb; 18(2):e1010266. PubMed ID: 35134097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.